Singapore markets close in 1 hour 55 minutes
Straits Times Index
3,290.64 -2.05 (-0.06%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,189.99 +426.96 (+2.40%) FTSE 100
8,121.24 0.00 (0.00%) Bitcoin USD
57,637.42 -1,655.92 (-2.79%) CMC Crypto 200
1,262.70 -8.04 (-0.63%)
Candel Therapeutics, Inc. (CADL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 234.19M |
| Enterprise value | 221.54M |
| Trailing P/E | 63.17 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 436.42 |
| Price/book (mrq) | 18.38 |
| Enterprise value/revenue | 821.98 |
| Enterprise value/EBITDA | -6.44 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.92 |
| 52-week change 3 | 369.41% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 11.40 |
| 52-week low 3 | 0.66 |
| 50-day moving average 3 | 3.43 |
| 200-day moving average 3 | 1.70 |
Share statistics
| Avg vol (3-month) 3 | 5.51M |
| Avg vol (10-day) 3 | 669.44k |
| Shares outstanding 5 | 29.35M |
| Implied shares outstanding 6 | 29.35M |
| Float 8 | 18.05M |
| % held by insiders 1 | 34.72% |
| % held by institutions 1 | 16.50% |
| Shares short (15 Apr 2024) 4 | 2.03M |
| Short ratio (15 Apr 2024) 4 | 0.13 |
| Short % of float (15 Apr 2024) 4 | 10.28% |
| Short % of shares outstanding (15 Apr 2024) 4 | 6.91% |
| Shares short (prior month 15 Mar 2024) 4 | 147.27k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -40.36% |
| Return on equity (ttm) | -125.50% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -37.43M |
| Net income avi to common (ttm) | -37.94M |
| Diluted EPS (ttm) | -1.31 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 35.41M |
| Total cash per share (mrq) | 1.21 |
| Total debt (mrq) | 22.76M |
| Total debt/equity (mrq) | 178.60% |
| Current ratio (mrq) | 2.59 |
| Book value per share (mrq) | 0.44 |
Cash flow statement
| Operating cash flow (ttm) | -34.24M |
| Levered free cash flow (ttm) | -21.57M |
© 2024 Yahoo. All rights reserved.